Nuvectis Pharma, Inc. Common Stock

NVCTNASDAQ • USD
20.22 USD
↘ 0.02 (0.12%)🟢PRE MARKET (AS OF 05:02 AM EST)
🟢Market: OPEN

Shares of Nuvectis Pharma, Inc. Common Stock (NVCT) are trading at $20.22. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. NVCT is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$19.93
High?$20.22
Low?$19.93
Prev. Close?$20.24
Volume?1.0K
Avg. Volume?196.4K
VWAP?$20.22
Rel. Volume?0.01x
Bid / Ask
Bid?$14.40 × 100
Ask?$25.08 × 100
Spread?$10.68
Midpoint?$19.74
Valuation & Ratios
Market Cap?696.0M
Shares Out?34.4M
Float?20.6M
Float %?63.1%
P/E Ratio?N/A
P/B Ratio?5.50
EPS?-$1.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Employees
13
Market Cap
696.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-02-04
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Phone: 360-837-7232
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?27.86Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.36%High
Short Interest?2.5M
Days to Cover?15.2
Free Float20.6M
Avg Daily Volume167.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.92Strong
Quick Ratio?9.92Strong
Cash Ratio?9.91Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
34
5.50FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-39.8%WEAK▾
ROA?
S&P
3
-35.8%WEAK▾
Cash Flow & Enterprise
FCF?$-40294000
Enterprise Value?$555.3M
Fundamentals ratios updated end of day